Rheumatology NewsRisankizumab outperforms placebo at 6 months for psoriatic arthritisNovember 8, 2021Psoriatic Arthritis
Rheumatology NewsHigher odds for preterm, C-section births seen in women with PsAOctober 28, 2021Psoriatic Arthritis
Rheumatology NewsBetter COVID-19 outcomes confirmed in TNF inhibitor usersOctober 22, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
Rheumatology NewsTramadol linked to higher risk of mortality, compared with codeineOctober 19, 2021PainOsteoarthritisRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Rheumatology NewsU.S. arthritis prevalence continues steady rise; activity limitations grow more rapidlyOctober 18, 2021OsteoarthritisRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisGoutLupus & Connective Tissue Diseases
Rheumatology NewsFew JAK inhibitor users have diminished immune response to COVID-19 vaccinesOctober 18, 2021COVID-19 UpdatesRheumatoid ArthritisPsoriatic Arthritis
Rheumatology NewsAdalimumab biosimilar Cyltezo gets interchangeability designationOctober 18, 2021Rheumatoid ArthritisSpondyloarthropathiesPediatricsPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Rheumatology NewsStudy of biologics’ impact on psoriasis-to-PsA transition contradicts previous findingsOctober 13, 2021Psoriatic Arthritis
Rheumatology NewsFirst-in-class TYK inhibitor shows durable effect for psoriasisOctober 1, 2021Psoriatic Arthritis
Rheumatology NewsAcceptance of biosimilars grows but greater use may hinge on switching, interchangeability studiesSeptember 30, 2021Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesPediatricsAnkylosing spondylitisLupus & Connective Tissue Diseases
Rheumatology NewsMore severe psoriasis linked to an increased risk of PsASeptember 28, 2021Psoriatic Arthritis
Rheumatology NewsEuropean agency recommends two new adalimumab biosimilarsSeptember 20, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsMedicare patients’ cost burden for specialty psoriasis, PsA drugs remains highSeptember 15, 2021Psoriatic Arthritis
